Table 4.
Stratification by age, frailty, and sex.
| Reference period 1 (04–06, 2012–2019) | Observation period 1 (04–06, 2020) | Change (%) | P | Reference period 2 (10–12, 2012–2019) | Observation period 2 (10–12, 2020) | Change (%) | P | |
|---|---|---|---|---|---|---|---|---|
| Gastric cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.27 | 0.24 | −11.1 | 0.173 | 0.25 | 0.21 | −16.0 | 0.157 |
| 60–74 | 2.08 | 1.70 | −18.3 | 0.008 | 1.87 | 1.47 | −21.4 | 0.057 |
| ≥75 | 3.20 | 2.37 | −25.9 | <0.001 | 2.83 | 2.13 | −24.7 | 0.077 |
| Females | 0.69 | 0.58 | −15.9 | 0.007 | 0.63 | 0.49 | −22.2 | 0.071 |
| Males | 1.09 | 0.90 | −17.4 | 0.004 | 0.97 | 0.81 | −17.5 | 0.161 |
| Colon cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.72 | 0.65 | −9.7 | 0.042 | 0.68 | 0.64 | −5.9 | 0.326 |
| 60–74 | 7.23 | 5.22 | −27.9 | <0.001 | 6.54 | 4.80 | −26.8 | <0.001 |
| ≥75 | 14.34 | 10.95 | −23.6 | <0.001 | 12.75 | 10.08 | −20.9 | 0.047 |
| Females | 3.14 | 2.38 | −24.2 | <0.001 | 2.78 | 2.29 | −17.6 | 0.038 |
| Males | 3.44 | 2.87 | −16.9 | <0.001 | 3.18 | 2.60 | −18.2 | 0.030 |
| Rectal cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.40 | 0.36 | −10.0 | 0.140 | 0.38 | 0.29 | −23.7 | 0.006 |
| 60–74 | 3.13 | 2.38 | −24.0 | 0.001 | 2.88 | 1.90 | −34.0 | 0.002 |
| ≥75 | 3.96 | 2.69 | −32.1 | <0.001 | 3.59 | 2.34 | −34.8 | 0.004 |
| Females | 0.93 | 0.73 | −22.6 | 0.006 | 0.86 | 0.65 | −25.6 | 0.015 |
| Males | 1.56 | 1.23 | −21.2 | <0.001 | 1.44 | 0.96 | −32.6 | 0.001 |
| Esophageal cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.16 | 0.15 | −6.3 | 0.372 | 0.14 | 0.10 | −28.6 | 0.028 |
| 60–74 | 1.06 | 1.06 | 0 | 0.966 | 0.97 | 0.72 | −25.8 | 0.057 |
| ≥75 | 0.63 | 0.63 | 0 | 0.964 | 0.62 | 0.42 | −33.3 | 0.043 |
| Females | 0.14 | 0.15 | +7.1 | 0.507 | 0.14 | 0.09 | −35.7 | 0.040 |
| Males | 0.58 | 0.58 | 0 | 0.898 | 0.53 | 0.40 | −24.5 | 0.042 |
| Pancreatic cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.17 | 0.16 | −5.9 | 0.389 | 0.15 | 0.13 | −13.3 | 0.400 |
| 60–74 | 1.54 | 1.37 | −11.0 | 0.026 | 1.40 | 1.03 | −25.7 | 0.039 |
| ≥75 | 1.53 | 1.68 | −9.8 | 0.306 | 1.44 | 1.34 | −6.9 | 0.625 |
| Females | 0.52 | 0.53 | +1.9% | 0.815 | 0.47 | 0.39 | −17.0 | 0.183 |
| Males | 0.57 | 0.56 | −3.5 | 0.589 | 0.53 | 0.47 | −11.3 | 0.347 |
| Lung cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.47 | 0.42 | −10.6 | 0.087 | 0.43 | 0.34 | −18.6 | 0.077 |
| 60–74 | 4.27 | 3.90 | −8.9 | 0.068 | 3.81 | 3.46 | −9.4 | 0.353 |
| ≥75 | 2.46 | 2.32 | −5.7 | 0.484 | 2.31 | 2.16 | −6.5 | 0.628 |
| Females | 1.00 | 1.05 | +5 | 0.513 | 0.92 | 0.93 | +1.1 | 0.920 |
| Males | 1.66 | 1.46 | −12.0 | 0.019 | 1.48 | 1.27 | −14.2 | 0.188 |
| Liver cancer | ||||||||
| Age | ||||||||
| ≤59 | 0.36 | 0.34 | −5.6 | 0.364 | 0.33 | 0.30 | −9.1 | 0.318 |
| 60–74 | 2.67 | 2.33 | −12.4 | 0.018 | 2.39 | 2.10 | −12.6 | 0.183 |
| ≥75 | 2.04 | 1.78 | −12.3 | 0.109 | 1.86 | 1.66 | −10.8 | 0.382 |
| Females | 0.70 | 0.65 | −7.1 | 0.211 | 0.65 | 0.58 | −9.2 | 0.345 |
| Males | 1.17 | 1.07 | −8.5 | 0.130 | 1.05 | 0.97 | −7.6 | 0.407 |
Rates are calculated based on population data of that age group (i.e. per 100 000 people of that age group, https://service.destatis.de/bevoelkerungspyramide/#!y).